View Older Stories View More Recent Stories

Feb 27, 2025 08:05AM New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change
Feb 20, 2025 04:05PM Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
Feb 10, 2025 07:00AM Guardant Health to Participate in Upcoming Investor Conferences
Jan 30, 2025 04:05PM Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
Jan 30, 2025 08:05AM Guardant Health’s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program
Jan 23, 2025 08:05AM Guardant Health (GH) to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools
Jan 23, 2025 08:05AM Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development
Jan 21, 2025 08:05AM Guardant Health Receives Medicare Coverage for Guardant Reveal™ on Smart Liquid Biopsy™ Platform for Surveillance Testing in Colorectal Cancer Patients
Jan 16, 2025 08:10AM Guardant Health (GH) and ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development
Jan 16, 2025 08:05AM Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development
Jan 13, 2025 07:00AM Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results
Jan 7, 2025 08:03AM Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
Jan 2, 2025 04:05PM Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Dec 20, 2024 08:05AM Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
Dec 19, 2024 06:00AM COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
Dec 18, 2024 08:06AM Guardant Health (GH) Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Dec 18, 2024 08:05AM Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Dec 9, 2024 08:05AM Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer
Nov 25, 2024 05:09PM Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™
Nov 13, 2024 05:05PM Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2024 04:05PM Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
Nov 1, 2024 07:00AM Guardant Health to Participate in Upcoming Investor Conferences
Oct 30, 2024 09:30AM Guardant Health Named to TIME’s List of the Best Inventions of 2024
Oct 28, 2024 08:05AM Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
Oct 24, 2024 05:06PM Guardant Health (GH) Appoints Roberto A. Mignone to its Board
Oct 24, 2024 05:05PM Roberto A. Mignone Joins Guardant Health Board of Directors
Oct 15, 2024 04:05PM Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024
Sep 18, 2024 08:05AM GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long
Sep 13, 2024 02:00AM Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
Sep 10, 2024 08:00AM Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
Aug 27, 2024 04:05PM Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Aug 22, 2024 05:00PM Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening
Aug 8, 2024 04:05PM Guardant Health to Participate in Upcoming Investor Conferences
Aug 7, 2024 04:05PM Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
Aug 7, 2024 08:05AM Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer
Aug 1, 2024 08:33AM Guardant Health's (GH) FDA-approved Shield Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
Aug 1, 2024 08:30AM Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
Aug 1, 2024 08:00AM Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies
Jul 29, 2024 07:34AM Guardant Health's (GH) Shield Blood Test Approved by FDA as Primary Screening Option, Clearing Path for Medicare Reimbursement
Jul 29, 2024 06:30AM Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
Jul 24, 2024 04:05PM Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
Jul 23, 2024 08:17AM Guardant Health (GH) Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test
Jul 23, 2024 08:05AM Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance
Jul 18, 2024 05:01PM Guardant Health (GH) Appoints Manuel Hidalgo Medina to its Board
Jul 18, 2024 05:00PM Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
Jun 4, 2024 08:05AM Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
Jun 3, 2024 09:18AM Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical t
May 31, 2024 08:05AM Guardant Health Named to TIME100 Most Influential Companies
May 30, 2024 08:05AM Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening
May 24, 2024 08:20AM Guardant Health (GH): FDA Advisory Committee Panel Strongly Recommends Approval of Shield Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
View More Recent Stories View Older Stories